Maryland recalls

Major Pharmaceuticals is recalling specific lots of Levothyroxine Sodium 125 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid replacement medication, and tablets that are weaker than expected could result in inadequate thyroid hormone levels.

Major Pharmaceuticals issued a recall of Levothyroxine Sodium 75 mcg tablets because some batches do not contain the full labeled amount of active ingredient. This means the medication may not work as intended for treating thyroid conditions. The affected batches have expiration dates of July 2026 and December 2026.

Major Pharmaceuticals levothyroxine sodium 50 mcg tablets in certain lots contain less active ingredient than labeled, meaning they may not work as intended. This affects specific lot numbers expiring in October 2026 that were distributed nationwide.

Major Pharmaceuticals levothyroxine sodium 25 mcg tablets in certain lots do not contain the full labeled amount of active ingredient. This means the medication may not work as intended to treat thyroid conditions. The affected lots (N02212A, N02212B, and blister lot N02212, all expiring 07/2026) were distributed nationwide.

Major Pharmaceuticals is recalling one lot of levothyroxine sodium 150 mcg tablets because they do not contain the full stated dose of active ingredient. Patients taking this medication need the correct dose to manage their thyroid condition properly.

Major Pharmaceuticals is recalling one lot of Levothyroxine Sodium Tablets, USP 125 mcg due to subpotency—meaning the tablets contain less active ingredient than expected. This affects lot #N02266 with an expiration date of 11/2026. The affected tablets were distributed nationwide.

Major Pharmaceuticals issued a recall of Levothyroxine Sodium 112 mcg tablets (Lot #N02203, expiring 09/2026) because the medication is subpotent—meaning it contains less active ingredient than labeled. Patients taking this lot may not receive the full intended dose of this thyroid replacement medication.

Major Pharmaceuticals issued a recall of Levothyroxine Sodium Tablets, USP, 88 mcg (Lot #N02310, expiration 01/2027) because the tablets may contain less active ingredient than labeled. This means patients taking this medication may not receive the full intended dose of thyroid hormone.

Major Pharmaceuticals is recalling certain lots of Levothyroxine Sodium Tablets, USP, 75 mcg because they may contain less active ingredient than labeled. Patients taking affected tablets may not receive the full intended dose of this thyroid hormone medication.

Major Pharmaceuticals is recalling levothyroxine sodium 50 mcg tablets (lot N02200, expiration 10/2026) because they do not contain the full labeled dose. Levothyroxine is a thyroid hormone replacement medication, and a subpotent tablet may not provide the intended therapeutic effect for patients who depend on consistent dosing.

Major Pharmaceuticals is recalling one lot of Levothyroxine Sodium Tablets, USP, 25 mcg due to subpotency — meaning the tablets contain less active ingredient than labeled. This affects Lot N02212 with an expiration date of 07/2026. Patients taking subpotent levothyroxine may not receive the full intended dose of this thyroid hormone replacement medication.

Precision Dose Inc. is recalling one lot of Glycopyrrolate Oral Solution (1 mg/5 mL) due to an unidentified impurity found during routine stability testing that does not meet specification. The affected lot (506033) expires November 30, 2026. This medication is prescription-only and supplied in unit-dose oral syringes.

Rooted in Rare brand Aquafaba Powder may contain undeclared egg, posing a serious allergic reaction risk for people with egg allergies or sensitivities. The recall affects 4 oz and 12 oz packages distributed through Amazon and the company website between June 2025 and July 2026.

Sunny Pharmtech is recalling three lots of Cyclophosphamide for Injection (1g and 2g vials) distributed between May 2024 and October 2024 because steel particles were found in the product. No injuries have been reported so far, but steel particles in an intravenous injection could cause serious complications including blood clots and infection.

Lidl US is recalling Eridanous Shortbread Cookies with Chocolate Truffle Coating & Apricot Filling (11.6 oz box, UPC 4056489125839) because the packaging has foreign language text only and does not clearly list wheat, soy, milk, and egg allergens in English. People with allergies or sensitivities to these ingredients could have serious reactions.

Baxter is recalling one lot of Cefazolin in Dextrose Injection (a frozen antibiotic infusion bag) because cardboard particles were found in the solution. The affected lot (LD175708, expiring February 14, 2027) was distributed between March and June 2025. No injuries have been reported so far.

American Regent identified glass and paraformaldehyde particles in one lot of Papaverine Hydrochloride Injection (Lot #25202), a prescription medication used to improve blood circulation and treat muscle spasms. The particles could cause local irritation, blood vessel blockage, and serious complications including stroke.

Snaps on Peony Design personalized baby bibs and stroller bags can detach, creating a choking hazard for young children. The bibs feature scalloped edges and personalized embroidery, while stroller bags have two snap-closure straps. About 52 items were sold online through Etsy between October 2025 and July 2026.

CuddleCubs Creations teething toy sets sold on Amazon contain pull-string toys with silicone strings that are longer and smaller than safety standards allow. These strings can reach the back of a child's throat and become lodged, creating a serious choking hazard.

OeyUoc white pool drain covers sold on Amazon do not meet federal safety standards for drain protection and pose a serious risk of entrapment and drowning. The covers violate the Virginia Graeme Baker Pool and Spa Safety Act, which requires drain covers to prevent people—especially children—from getting trapped.

Sviyatp white pool drain covers do not meet federal safety standards and pose a risk of entrapment and drowning. The covers were sold online as replacement drain covers for swimming pools from March through June 2026.

Aojieni Silicone pull string teething toys have silicone strings that are longer and smaller than safety standards allow. The strings can reach the back of a child's throat and become lodged, creating a serious choking hazard. One child experienced gagging when the strings reached their throat.

Romorgniz 12-drawer fabric dressers sold on Amazon are unstable and can tip over if not anchored to a wall, creating a serious injury or death risk to children. The dressers do not meet federal safety standards for clothing storage units.

EnHomee 9-Drawer Fabric Dressers can tip over and trap children if not anchored to the wall. The dressers do not meet federal safety standards required for clothing storage units. About 16,800 units were sold online through Walmart.com between September 2023 and March 2026.

Tosoh Bioscience recalled certain lots of its ST AIA-Pack Testosterone test due to a quality control issue that can produce falsely high or falsely low testosterone measurements. Inaccurate results may lead to unnecessary follow-up testing or delayed diagnosis.

The Photera 600 3-D ultraviolet phototherapy device used to treat skin disorders has a calibration error in how it calculates UV output. A sensor setting was incorrectly applied, causing the device to deliver lower UV intensity than intended. This affects 212 units distributed nationwide.

The Photera 600 ultraviolet phototherapy device was found to have an error in how it calculates UV output. A sensor setting was incorrect, causing the device to deliver lower UV levels than intended. This affects 26 units with specific serial numbers distributed nationwide.

The Photera 400 ultraviolet phototherapy device uses a sensor to measure and control UV output for treating skin disorders. A calibration error caused the sensor to report incorrect UV levels, which means patients may have received different doses than intended.

Maquet (now Getinge) identified that 205 units of the Vasoview Hemopro 2 endoscopic vessel harvesting system from a single lot were exposed to an incorrect sterilization dose during gamma sterilization processing. This occurred at a STERIS facility in New Jersey in late March 2026. The affected devices may not be adequately sterilized.

3B Medical is recalling Rio II nasal pillows interfaces due to a packaging and labeling discrepancy affecting product size identification and device identifiers. The affected units have incorrect or mismatched labeling on certain lots, which could lead to patients receiving the wrong size for their CPAP or PAP therapy device.